During the last decades, the term “drug delivery systems”(DDSs) has almost fully replaced
previously used terms, such as “dosage forms”, in an attempt to emphasize the importance …

Respiratory diseases are among the leading causes of morbidity and mortality worldwide.
Innovations in biochemical engineering and understanding of the pathophysiology of …

Introduction Proper device selection is crucial for the clinical results of inhalation therapy.
However, none of the available devices fully conforms to the requirements for delivering …

The rapid and non-invasive pulmonary drug delivery (PDD) has attracted great attention
compared to the other routes. However, nanoparticle platforms, like liposomes (LPs) and …

Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with
few systemic side effects. In addition, it is non-invasive and has good patient compliance …

This article reviews recent developments in computational modeling of dry powder inhalers
(DPIs). DPIs deliver drug formulations (sometimes blended with larger carrier particles) to a …

Aerogel technology is an emerging platform that offers alternative and cost-effective dry
carriers with advanced performances for the pharmaceutical industry. The innovative …

Highlights•The pulmonary route is an efficient route for respiratory diseases.•Technosphere
® and PulmoSphere™ are novel inhalable technologies for drug delivery.•Microparticles are …

Mesoporous materials are structures characterized by a well-ordered large pore system with
uniform porous dimensions ranging between 2 and 50 nm. Typical samples are zeolite …

Pulmonary drug delivery has recognized benefits for both local and systemic treatments. Dry
powder inhalers (DPIs) are convenient, portable and environmentally friendly devices …